Total Payments
$17,192
2024 Payments
$505.29
Companies
62
Transactions
802
Medicare Patients
2,812
Medicare Billing
$211,004
Payment Breakdown by Category
Food & Beverage$15,097 (87.8%)
Consulting$1,200 (7.0%)
Travel$722.68 (4.2%)
Education$172.09 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,097 | 788 | 87.8% |
| Consulting Fee | $1,200 | 1 | 7.0% |
| Travel and Lodging | $722.68 | 3 | 4.2% |
| Education | $172.09 | 10 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,447 | 128 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,301 | 95 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $2,026 | 17 | $0 (2022) |
| ABBVIE INC. | $1,445 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $972.15 | 63 | $0 (2024) |
| Lilly USA, LLC | $889.43 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $792.50 | 36 | $0 (2022) |
| Merck Sharp & Dohme LLC | $629.66 | 58 | $0 (2023) |
| Astellas Pharma US Inc | $584.68 | 22 | $0 (2023) |
| Amarin Pharma Inc. | $490.44 | 39 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $505.29 | 17 | Lilly USA, LLC ($258.62) |
| 2023 | $1,619 | 73 | ABBVIE INC. ($300.79) |
| 2022 | $3,936 | 87 | Biohaven Pharmaceutical Holding Company Ltd. ($2,026) |
| 2021 | $1,858 | 82 | AbbVie Inc. ($250.31) |
| 2020 | $1,181 | 48 | AstraZeneca Pharmaceuticals LP ($385.97) |
| 2019 | $2,254 | 125 | AstraZeneca Pharmaceuticals LP ($459.08) |
| 2018 | $2,997 | 169 | Novo Nordisk Inc ($498.16) |
| 2017 | $2,842 | 201 | Novo Nordisk Inc ($585.59) |
All Payment Transactions
802 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $108.03 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: DIABETES | ||||||
| 08/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Inari Medical, Inc. | CT THROMBECTOMY SYSTEM KIT (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: VTE | ||||||
| 07/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Obesity | ||||||
| 06/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: DIABETES | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Obesity | ||||||
| 04/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: UROLOGY | ||||||
| 04/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $121.80 | General |
| Category: Obesity | ||||||
| 03/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Obesity | ||||||
| 02/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 01/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Respiratory | ||||||
| 11/30/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Obesity | ||||||
| 11/28/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 11/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 761 | 953 | $225,374 | $62,941 |
| 2022 | 13 | 665 | 838 | $273,826 | $52,880 |
| 2021 | 18 | 812 | 984 | $166,760 | $55,839 |
| 2020 | 12 | 574 | 748 | $120,517 | $39,344 |
Total Patients
2,812
Total Services
3,523
Medicare Billing
$211,004
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 337 | $113,848 | $25,890 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 163 | 163 | $56,715 | $20,020 | 35.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $13,648 | $5,643 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 90 | $21,176 | $4,414 | 20.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 46 | 46 | $9,522 | $3,230 | 33.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 99 | 108 | $4,077 | $872.39 | 21.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 49 | 49 | $1,004 | $828.60 | 82.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 17 | 18 | $1,619 | $795.96 | 49.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $1,275 | $535.13 | 42.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $642.00 | $246.26 | 38.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 23 | $898.00 | $236.94 | 26.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $502.00 | $178.20 | 35.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 16 | $101.00 | $35.20 | 34.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 16 | $48.00 | $13.79 | 28.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 17 | 23 | $299.00 | $2.17 | 0.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 276 | $185,428 | $23,145 | 12.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 123 | 123 | $39,299 | $15,804 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 138 | $30,536 | $7,324 | 24.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $6,150 | $2,379 | 38.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $3,936 | $1,645 | 41.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 32 | 32 | $2,336 | $908.16 | 38.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 84 | 93 | $3,279 | $753.43 | 23.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $675.00 | $314.79 | 46.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 29 | $1,016 | $292.25 | 28.8% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2022 | 11 | 11 | $440.00 | $172.56 | 39.2% |
About Dr. Abel Garduno, M.D
Dr. Abel Garduno, M.D is a Family Medicine healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336184787.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abel Garduno, M.D has received a total of $17,192 in payments from pharmaceutical and medical device companies, with $505.29 received in 2024. These payments were reported across 802 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($15,097).
As a Medicare-enrolled provider, Garduno has provided services to 2,812 Medicare beneficiaries, totaling 3,523 services with total Medicare billing of $211,004. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Plano, TX
- Active Since 06/19/2006
- Last Updated 07/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1336184787
Products in Payments
- NURTEC ODT (Drug) $2,212
- FARXIGA (Drug) $1,622
- UBRELVY (Drug) $935.51
- Ozempic (Drug) $620.86
- Vascepa (Drug) $490.44
- JARDIANCE (Drug) $451.52
- Tresiba (Drug) $451.37
- INVOKANA (Drug) $397.61
- XARELTO (Drug) $394.89
- JANUVIA (Drug) $366.78
- SHINGRIX (Biological) $332.61
- Saxenda (Drug) $327.23
- Myrbetriq (Drug) $316.96
- TRULICITY (Drug) $298.18
- TOUJEO (Drug) $273.94
- Victoza (Drug) $263.46
- MOUNJARO (Drug) $259.97
- RYBELSUS (Drug) $233.39
- BREO (Drug) $217.27
- DEXCOM G7 GSS (161) (Medical Supply) $212.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Plano
Dr. Mahdi Awwad, M.d, M.D
Family Medicine — Payments: $24,534
Family Medicine $24,534
Elaine Timm, Md, MD
Family Medicine — Payments: $19,841
Family Medicine $19,841
Mr. Jose Trevino, Md, MD
Family Medicine — Payments: $18,709
Family Medicine $18,709
John Moon, M.d, M.D
Family Medicine — Payments: $18,442
Family Medicine $18,442
Dr. Yan Li, M.d., Ph.d, M.D., PH.D
Family Medicine — Payments: $17,814
Family Medicine $17,814
Dr. Todd Wien, Md, MD
Family Medicine — Payments: $13,547
Family Medicine $13,547